Overview Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function Status: RECRUITING Trial end date: 2024-10-12 Target enrollment: Participant gender: Summary Evaluate the Safety and Pharmacokinetics of MBX 2109 in Adult Subjects with Normal and Impaired Renal FunctionPhase: PHASE1 Details Lead Sponsor: MBX Biosciences